In this study, we analyzed paired samples at the initial diagnosis and transformation to AML in eight ET patients, and identified three patients in whom JAK2-unmutated AML clones developed from JAK2-mutated ET in the chronic phase. The gene discussed is JAK2; the disease is essential thrombocythemia.